Connect with us

Hi, what are you looking for?

FDA Acknowledgement of Mercury Amalgam Risks Is a Big Step Forward, Says Biological Dental Group

HOUSTON, TX / ACCESSWIRE / October 13, 2020 / The FDA took an important step forward last month when they issued new guidance on dental amalgam – the material used to make "silver" fillings. Despite their name, however, the fillings are about 50% mercury.

That neurotoxic metal does not stay locked in the filling but is released over time. Some may be excreted, but some is absorbed by organs such as the brain.

Because of this, the FDA now advises against its use in pregnant and nursing women, women who plan on getting pregnant, children, and people with pre-existing neurological conditions, impaired kidney function, or sensitivities to mercury or other components of amalgam.

"A proud day has arrived," said Dr. Dawn Ewing, executive director of the International Academy of Biological Dentistry and Medicine, a professional association that has been the vanguard of nontoxic, whole body dentistry since its founding by California dentists Dr. Ed Arana and Dr. Gary Verigin in 1985.

"I can remember when several states had 'gag orders'," she continued. "Their state boards did NOT want dentists making any comments about amalgams. They didn't want to admit that there might be a problem, even for some people. One of our early members, Dr. Andy Landerman, lost his license in California for refusing to place amalgam restorations. He passed away several years ago. All I can think of is how sweet it must be for him – and dentists like him – to look down and see that he was right. We are grateful for those brave souls!"

IABDM Past President Dr. Bill Glaros agreed, "I have been grateful to be a part of this organization, celebrating a common path – the path toward a dentistry that acknowledges the role conditions in the mouth play on overall health. The FDA's latest action would not have been possible without the work of our amazing members – and, of course, the tireless efforts of people like Charlie Brown through Consumers for Dental Choice and the World Alliance for Mercury-Free Dentistry."

"Charlie has carried the flag for all of us," added physician Dr. John Parks Trowbridge, who has also served as a president of the IABDM and is the group's current medical advisor. "His tireless work produces impressive and lasting results every single year. The path is long and steep, but he – and we – are getting closer to ultimate success for ourselves, our children, our grandchildren: a future where dental amalgam is nothing but a bad memory!"

About the IABDM: The International Academy of Biological Dentistry and Medicine is a network of dentists, physicians and allied health professionals committed to integrating body, mind, spirit and mouth in caring for the whole person. It was founded in 1985 to teach and promote a more informed dentistry – one that fully accounts for the systemic nature of health and illness, and the body's self-regulating ability. To learn more, visit iabdm.org.

###

For more information about International Academy of Biological Dentistry & Medicine, contact the company here:

International Academy of Biological Dentistry & Medicine
Dawn Ewing
281-251-4411
drdawn@drdawn.net

SOURCE: International Academy of Biological Dentistry & Medicine

View source version on accesswire.com:
https://www.accesswire.com/610340/FDA-Acknowledgement-of-Mercury-Amalgam-Risks-Is-a-Big-Step-Forward-Says-Biological-Dental-Group

AccessWire
Written By

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.

You may also like:

Business

Meta's growth is due in particular to its sophisticated advertising tools and the success of "Reels" - Copyright AFP SEBASTIEN BOZONJulie JAMMOTFacebook-owner Meta on...

Business

The job losses come on the back of a huge debt restructuring deal led by Czech billionaire Daniel Kretinsky - Copyright AFP Antonin UTZFrench...

Tech & Science

TikTok on Wednesday announced the suspension of a feature in its spinoff TikTok Lite app in France and Spain.

Tech & Science

AI and ML are streamlining clinical trials, delivering validated real-time data to decision-making teams faster and with more accuracy.